The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer

References

• Socialstyrelsen. Cancer incidence in Sweden 2010. Stockholm: Socialstyrelsen; 2011.
   Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001;23:389–98.
   PubMed Web of Science ®Google Scholar
• Kreeft A, Molen L, Hilgers F, Balm A. Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: A systematic review of the literature. Eur Arch Oto-Rhino-Laryngol 2009;266:1687–98.
   PubMed Web of Science ®Google Scholar
• Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337–42.
   PubMed Web of Science ®Google Scholar
• Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A. Prediction of post-treatment trismus in head and neck cancer patients. Br J Oral Maxillofac Surg 2012;50:328–7.
   PubMed Web of Science ®Google Scholar
• Johnson J, van As-Brooks CJ, Fagerberg-Mohlin B, Finizia C. Trismus in head and neck cancer patients in Sweden: Incidence and risk factors. Med Sci Monit 2010;16: CR278–82.
   Web of Science ®Google Scholar
• Goldstein M, Maxymiw WG, Cummings BJ, Wood RE. The effects of antitumour irradiation on mandibular opening and mobility: A prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 1999;88:365–73.
   PubMed Web of Science ®Google Scholar
• Ichimura K, Tanaka T. Trismus in patients with malignant tumours in the head and neck. J Laryngol Otol 1993;107: 1017–20.
   PubMed Web of Science ®Google Scholar
• Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 2010;18:1033–8.
   PubMed Web of Science ®Google Scholar
• Corry J, Peters LJ, Rischin D. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol 2010;11:287–91.
   PubMed Web of Science ®Google Scholar
• Hutcheson KA, Lewin JS. Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers. Current Oncol Report 2012;14:158–65.
   PubMed Web of Science ®Google Scholar
• Weber C, Dommerich S, Pau HW, Kramp B. Limited mouth opening after primary therapy of head and neck cancer. Oral Maxillofac Surg 2010;14:169–73.
   PubMedGoogle Scholar
• Scott B, D’Souza J, Perinparajah N, Lowe D, Rogers SN. Longitudinal evaluation of restricted mouth opening (trismus) in patients following primary surgery for oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg 2011;49:106–11.
   PubMed Web of Science ®Google Scholar
• Louise Kent M, Brennan M, Noll J, Fox P, Burri S, Hunter J, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 2008;16:305–9.
   PubMed Web of Science ®Google Scholar
• Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45:2220–4.
   PubMed Web of Science ®Google Scholar
• Paleri V, Wight RG, Silver CE, Haigentz Jr M, Takes RP, Bradley PJ, et al. Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice. Oral Oncol 2010;46:712–9.
   PubMed Web of Science ®Google Scholar
• Sobin L, Gospodarowicz M, Wittekind C, editors. TNM classification of malignant tumours, 7th ed. Chicester: Wiley-Blackwell; 2009.
   Google Scholar
• Johnson J, Carlsson S, Johansson M, Pauli N, Ryden A, Fagerberg-Mohlin B, et al. Development and validation of the Gothenburg Trismus Questionnaire (GTQ). Oral Oncol Epub 2012;48:730–6.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–76.
   PubMed Web of Science ®Google Scholar
• Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ, et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. Acta Oncol 1994;33:879–85.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: A meta-analysis. J Affect Disorders 2010;126:335–48.
   PubMed Web of Science ®Google Scholar
• Wang C-J, Huang E-Y, Hsu H-C, Chen H-C, Fang F-M, Hsiung C-Y. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 2005;115:1458–60.
   PubMed Web of Science ®Google Scholar
• Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biorklund A, et al. A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 2001;111:1440–52.
   PubMed Web of Science ®Google Scholar
• Hammerlid E, Ahlner-Elmqvist M, Bjordal K, Biorklund A, Evensen J, Boysen M, et al. A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999;80:766–74.
   PubMed Web of Science ®Google Scholar